Uncategorized

HIV Lecture in Houston – July 12

Open to patients and clinicians Date: Wednesday, July 12 Time : 6:30 pm – 8:30 pm Place: Lovett Inn ( https://www.lovettinn.com/main.php ) Speakers: Dr Shannon Schrader and Nelson Vergel TOPICS: 1- Updated review of HIV pipeline products 2- How to best maximize the effects of Prezista, the newly approved protease inhibitor for multi-protease resistant virus […]

HIV Lecture in Houston – July 12 Read More »

Prezista’s( a new HIV protease inhibitor) approval today- My comments

Prezista (TMC 114, a new protease inhibitor) got approved by the FDA today. I have a few comments for those wishing to start this drug. First, avoid virtual monotherapy at all costs, if you can. Virtual monotherapy means adding a new drug to a failing regimen to which your virus has developed resistance. This approach

Prezista’s( a new HIV protease inhibitor) approval today- My comments Read More »

Update on Current Options in the US for HIV-related Facial Wasting

Gang Some of you have emailed me to ask me about my opinions lately on the most popular options for facial reconstruction. I have been following this field for almost 7 years now and my opinions have evolved with time. I have realized that there is place for each of the facial reconstruction products in

Update on Current Options in the US for HIV-related Facial Wasting Read More »

Fort Lauderdale and Miami Lectures in June

JUNE 6 6:00 PM Free Dinner Artserve Auditorium located at 1350 EAST SUNRISE BLVD. Fort Lauderdale (Broward County Library Building right next to the auto dealers & Holiday Park) Topics: How to qualify for a free wellness program in Ft Lauderdale,Upcoming new HIV medications and Clinical Trials,Exercise, body composition and HIV,The effects of Alcohol and

Fort Lauderdale and Miami Lectures in June Read More »

WallStreet Journal’s article on Salvage Therapy

As AIDS Drugs Fail Thousands, ‘Salvage’ Is Key By MARILYN CHASEMay 3, 2006; Page B1https://online.wsj.com/article/SB114660908687541895.html Steve Kovacev, a sinewy 52-year-old from Truro, Mass., has run the Boston Marathon and sailed in the Transpacific Yacht Race from Los Angeles to Honolulu. Neither event comes close to his current competition: a race for his life. Mr. Kovacev

WallStreet Journal’s article on Salvage Therapy Read More »

Appeals Court Rules that Terminally Ill Patients Have ‘Fundamental Right’ to Experimental Drugs

ugsFrom a Washington Legal Foundation (WLF) press release: Appeals Court Rules that Terminally Ill Patients Have ‘Fundamental Right’ to Experimental Drugs (Abigail Alliance v. Eschenbach) WASHINGTON, May 2, 2006-In a major victory for the Washington Legal Foundation (WLF), the U.S. Court of Appeals for the District of Columbia Circuit ruled today that terminally ill patients

Appeals Court Rules that Terminally Ill Patients Have ‘Fundamental Right’ to Experimental Drugs Read More »

Consensus Statement on the Pricing of TMC114 /Darunavir

Consensus Statement on the Pricing of TMC114 /DarunavirApril 17, 2006 TMC114/darunavir will soon become Tibotec’s first licensed drug for the treatment of HIV disease. It is likely to be the first of several important anti-HIV drugs from Tibotec. To date, the HIV/AIDS community’s relations with Tibotec have been exemplary as the company has shown an

Consensus Statement on the Pricing of TMC114 /Darunavir Read More »